Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (411-420 of 759) with videos related to

Pageof 76
Sort By:
Journal of the American Society of Nephrology : JASN|June 15, 2016
Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CIISamih H Nasr, Surendra Dasari, Linda Hasadsri, et al.
American Journal of Hematology|March 20, 2013
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphomaTaxiarchis V Kourelis, Morie Gertz, Clive Zent, et al.
Blood|August 28, 2024
Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapyRajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, et al.
Clinical Chemistry|August 13, 2016
Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass SpectrometryMindy C Kohlhagen, David R Barnidge, John R Mills, et al.
American Journal of Hematology|January 28, 2023
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choiceVaishali Sanchorawala, Ashutosh D Wechalekar, Kihyun Kim, et al.
British Journal of Haematology|November 19, 2013
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemiaAneel Paulus, Kasyapa Chitta, Sharoon Akhtar, et al.
JACC. Cardiooncology|November 29, 2022
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA TrialMonique C Minnema, Angela Dispenzieri, Giampaolo Merlini, et al.
Blood|June 24, 2008
Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2Bonnie K Arendt, Marina Ramirez-Alvarado, Laura A Sikkink, et al.
Kidney International Reports|May 2, 2022
Kidney Transplant Outcomes of Patients With Multiple MyelomaCihan Heybeli, Andrew J Bentall, Mariam Priya Alexander, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
Pageof 76

Showing results (411-420 of 759) with videos related to

Sort By:
Pageof 76
Journal of the American Society of Nephrology : JASN|June 15, 2016
Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CIISamih H Nasr, Surendra Dasari, Linda Hasadsri, et al.
American Journal of Hematology|March 20, 2013
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphomaTaxiarchis V Kourelis, Morie Gertz, Clive Zent, et al.
Blood|August 28, 2024
Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapyRajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, et al.
Clinical Chemistry|August 13, 2016
Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass SpectrometryMindy C Kohlhagen, David R Barnidge, John R Mills, et al.
American Journal of Hematology|January 28, 2023
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choiceVaishali Sanchorawala, Ashutosh D Wechalekar, Kihyun Kim, et al.
British Journal of Haematology|November 19, 2013
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemiaAneel Paulus, Kasyapa Chitta, Sharoon Akhtar, et al.
JACC. Cardiooncology|November 29, 2022
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA TrialMonique C Minnema, Angela Dispenzieri, Giampaolo Merlini, et al.
Blood|June 24, 2008
Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2Bonnie K Arendt, Marina Ramirez-Alvarado, Laura A Sikkink, et al.
Kidney International Reports|May 2, 2022
Kidney Transplant Outcomes of Patients With Multiple MyelomaCihan Heybeli, Andrew J Bentall, Mariam Priya Alexander, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
Pageof 76